Clinical Trial Update: The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigates whether pre-existing cross-reactive antibodies affect vaccine efficacy against yellow fever and Japanese encephalitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis
• Yellow Fever

Snippet

Sponsor: Singapore General Hospital | Conditions: Yellow Fever, Encephalitis, Japanese | Phase 2 | Status: COMPLETED